SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Takeda Pharmaceutical Company Limited – TAKAllbiopro2019-06-29T11:05:32+09:006월 29th, 2019|
Chi-Med Announces Pricing of Upsized U.S. Public Secondary Offering of American Depositary SharesAllbiopro2019-06-29T11:04:59+09:006월 29th, 2019|
Greenbrook TMS Announces Results of Voting at Annual and Special Meeting of ShareholdersAllbiopro2019-06-29T11:04:30+09:006월 29th, 2019|
Lou Kennedy Named Health Care Entrepreneur of the YearAllbiopro2019-06-29T11:04:01+09:006월 29th, 2019|
CARRICK THERAPEUTICS ANNOUNCES PLAN TO ESTABLISH US OPERATIONS AND APPOINTMENT OF TIM PEARSON AS CEOAllbiopro2019-06-29T11:03:34+09:006월 29th, 2019|
Chi-Med Announces Secondary Offering of American Depositary SharesAllbiopro2019-06-29T11:03:05+09:006월 29th, 2019|
Pancreatic Cancer Action Network Furthers Research Investment Through Funding Of Scientific GrantsAllbiopro2019-06-29T11:02:37+09:006월 29th, 2019|
Draper and Bristol-Myers Squibb Ink Toxicity Testing DealAllbiopro2019-06-29T11:01:41+09:006월 29th, 2019|
Karuna Therapeutic IPO to Raise $89.2 Million for Neuropsychiatric Drug DevelopmentAllbiopro2019-06-29T11:01:13+09:006월 29th, 2019|
Another Win For Darzalex as FDA Approves Combination Treatment For Multiple MyelomaAllbiopro2019-06-29T11:00:19+09:006월 29th, 2019|
Research Roundup: A Deeper Understanding of Alzheimer’sAllbiopro2019-06-29T10:59:50+09:006월 29th, 2019|
BioSpace Movers and Shakers: Ambys, Decibel, Verona, and MoreAllbiopro2019-06-29T10:59:23+09:006월 29th, 2019|
FDA Greenlights Alexion’s Soliris for Rare Autoimmune DiseaseAllbiopro2019-06-29T10:58:54+09:006월 29th, 2019|
Senate Committees Advance Prescription Price Lowering BillsAllbiopro2019-06-29T10:58:26+09:006월 29th, 2019|
New Research Discovery – Alzheimer’s and Toxicity PathwaysAllbiopro2019-06-29T10:57:59+09:006월 29th, 2019|
Scott Gottlieb Joins Pfizer Board Weeks After Departing from FDAAllbiopro2019-06-29T10:57:31+09:006월 29th, 2019|
